OTC/SmallCap IRW
Cloopen Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
BEIJING, Dec. 24, 2025 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has received a preliminary non-binding proposal letter (the "Proposal"), datedDecember 22, 2025, from Mr. Changxun Sun, the Comp...
2025-12-24 20:00
1522
Highway Holdings Plans to Acquire 51% of Regent-Feinbau Adermann GmbH
HONG KONG, Dec. 23, 2025 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today announced it has signed a letter of intent ("LOI") with LeMALe Beteiligungs-GmbH ("LeMaLe" or "Seller") to acquire 51% of German-based Regent-Feinbau Adermann GmbH ("Regent-...
2025-12-23 20:00
3157
King Resources, Inc. (OTC: KRFG) Subsidiary Heavenly Grace Limited Achieves Major Revenue Milestone with US$574,310 Sale of Rare Collectibles
HONG KONG, Dec. 22, 2025 /PRNewswire/ -- King Resources, Inc. (OTC: KRFG) ("KRFG" or the "Company"), is pleased to announce that its indirect wholly-owned subsidiary, Heavenly Grace Limited ("HGL"), has successfully completed the sale of five rare collectible artifacts to Mirum Digital Media Lim...
2025-12-22 21:18
3584
Kazia Therapeutics Regains Full Nasdaq Listing Compliance
Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therap...
2025-12-22 21:00
2820
Chinese Wuxia Game Shines on the Global Stage as CreateAI Wins Pinnacle Award Platinum
Open-world RPG "Heroes of Jin Yong" Named Category Benchmark, Capping CreateAI's 2025 Global Expansion Strategy SAN DIEGO and BEIJING, Dec. 19, 2025 /PRNewswire/ -- CreateAI (OTCMKTS: TSPH) ("CreateAI" or the "Company"), today announced that its upcoming open-world RPG, Heroes ofJin Yong, has wo...
2025-12-19 15:53
4978
HIGHWAY HOLDINGS REPORTS SECOND QUARTER FISCAL YEAR 2026 RESULTS
HONG KONG, Dec. 15, 2025 /PRNewswire/ -- Highway Holdings Limited (Nasdaq: HIHO, the "Company" or "Highway Holdings") today reported results for the second quarter of fiscal year 2026 and the six months endedSeptember 30, 2025. Net sales for the second quarter of fiscal year 2026 were $1.18 milli...
2025-12-15 20:00
2666
ReTo Eco-Solutions Subsidiary Showcases Equipment and Intelligent Solutions at Excon 2025 to Advance India Market Presence
BEIJING, Dec. 12, 2025 /PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company") today announced that its wholly owned subsidiary, Beijing REIT Equipment Technology Co., Ltd. ("REIT Equipment"), is participating in Excon 2025, a major construction equipment exhibition in B...
2025-12-12 21:00
3464
Locksley Commences Engineering Partner Selection Process for Its Desert Antimony Mine
SAN BERNARDINO, Calif., Dec. 11, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQX: LKYRF) announced the company has formally commenced the engineering partner selection process for the upcoming engineering scoping pilot plant design, following direct engagement with Tier 1 U.S. servi...
2025-12-11 21:45
2615
Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+
First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions...
2025-12-10 21:00
4193
ALR TECHNOLOGIES TO RELAUNCH THE GLUCURVE PET CGM IN JANUARY 2026
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the " Company") (OTC: ALRTF), the diabetes management company, announces the successful completion of internal manufacturing testing on the GluCurve Pet CGM ("GluCurve") showing accuracy results comparative to the leading v...
2025-12-08 22:14
2553
Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy
SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximatelyA$17 million via a placement of new shares at A$0.24 ...
2025-12-08 21:30
2006
Marvion Inc. Signs Exclusive Client Referral MOU with STAR Warehouse Engineering Limited, Strengthening Warehouse Engineering, Logistics Capacity and Corporate Client Acquisition
HONG KONG, Dec. 5, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) today announced that it has entered into a12-month binding Memorandum of Understanding (MOU) with STAR Warehouse Engineering Limited ("STAR"). Under the agreement, STAR willexclusively and with priority refer its engineering clien...
2025-12-05 21:18
3934
China Automotive Systems Advances High-Torque Intelligent Steering Motors to Mass Production for Commercial Vehicles
WUHAN, China, Dec. 5, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier inChina, today announced that its subsidiary, Hyoseong ( Wuhan) Motion Mechatronics System Co. Ltd., has entered the final co...
2025-12-05 19:00
3585
PINTEC TO HOLD EXTRAORDINARY GENERAL MEETING ON JANUARY 8, 2026
BEIJING, Dec. 4, 2025 /PRNewswire/ -- Pintec Technology Holdings Limited (NASDAQ: PT) ("Pintec" or the "Company"), a technology platform committed to enabling innovative financial and digital solutions for businesses worldwide, today announced that the Company will hold its extraordinary general ...
2025-12-05 05:00
3105
Kazia Therapeutics Announces Pricing of $50.0 Million Private Placement of Equity Securities
SYDNEY, Dec. 2, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, today announced that it has entered into a securities purchase agreement with certain established institutional and accredited investors for a private placement of equity ...
2025-12-02 22:00
2071
MaxsMaking Inc. Addresses SEC Trading Suspension and Affirms Full Cooperation with Regulators
SHANGHAI, Dec. 1, 2025 /PRNewswire/ -- MaxsMaking Inc. (Nasdaq: MAMK) ("MaxsMaking" or the "Company"), a manufacturer of customized consumer goods with a focus on advanced technology and innovation, addresses the ten-day Order of Suspension of Trading in the securities of the Company entered by t...
2025-12-01 19:00
2124
CN Energy Group. Inc. Announces Launch of PATHENBOT Robotics Solutions Platform and PATHENBOT's Official Website
LISHUI, China, Dec. 1, 2025 /PRNewswire/ -- CN Energy Group. Inc. ("CNEY" or the "Company") (NASDAQ: CNEY), a Nasdaq-listed company, today announced that its wholly owned subsidiary, PATHENBOT Group Inc. ("PATHENBOT"), has launched its robotics solutions platform and its official website (www.pat...
2025-12-01 18:55
2120
Nagarro expands in Japan with the acquisition of Inaho Digital Solutions
TOKYO, Nov. 26, 2025 /PRNewswire/ -- Nagarro, a global leader in digital engineering, announced today the acquisition of Inaho Digital Solutions (IDS), a boutique IT service provider specialized in modernizing legacy applications and in SAP S/4HANA transformations inJapan and for Japanese clients...
2025-11-26 19:06
2108
Marvion Inc. (OTC: MVNC) Delivers Strong Q3 Profitability and Secures New HK$720,000 Annual Storage Contract with Client Relocating to New Warehouse on 1 January 2026
HONG KONG, Nov. 24, 2025 /PRNewswire/ -- Marvion Inc. (OTCQB: MVNC) is pleased to announce two major milestones that further strengthen the Company's financial momentum and long-term growth outlook. Q3 Results: Revenue Growth Over 140% and Return to Profitability Based on the Company's recently ...
2025-11-24 21:14
2424
Kazia Therapeutics Achieves Initial iCR (Immune-Complete Response) in Metastatic TNBC and Delivers Q4 Business Update with Breakthroughs Across Breast Cancer, Immuno-Oncology, and GBM Regulatory Strategy
SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxali...
2025-11-19 05:15
2220
Week's Top Stories
Most Reposted
One Universal Production Group (OUP) Officially Opens, Reinforcing Its Position as Asia's Leading IP Ecosystem and Tourism Company
[Picked up by 315 media titles]
2025-12-20 09:36
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 297 media titles]
2025-12-23 14:23
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 270 media titles]
2025-12-26 12:55The Grand Opening of Dreame Hong Kong Flagship Store Showcases Full Product Lineup
[Picked up by 270 media titles]
2025-12-21 12:42
Fijian and Chinese Scholars Gather to Discuss Bilateral Friendship and the Outlook for APEC 2026
[Picked up by 263 media titles]
2025-12-22 15:56
